Navigation Links
Prothrombin Time Comes in Small (CLIA-Waived) Packages


Determining prothombin levels is necessary to plan or evaluate anticoagulant therapy, to diagnose various inherited conditions, such as hyperhomocystinemia, elevated factor VIII levels, dysfibrinogenemia, factor XII deficiency and disorders of plasmin generation, and to assess acquired conditions, such as pregnancy, postoperative state, antiphospholipid syndrome, hyperhomocystinemia, among others. Prothrombin levels are also monitored along with other tests (such as aspirate aminotransferase and alanine aminotransferase) to help evaluate liver function. Given the broad applicability of this test, it is helpful to many clinicians that several point-of-care products are now available for the prompt, accurate determination of prothombin levels.

Prothrombin time (PT) is the sole test used to measure the effectiveness of coumarin-type anticoagulant drugs, such as warfarin sodium (Coumadin). The most common methods to report the PT are the clotting interval (in seconds) and the International Normalized Ratio (INR). Targets for the INR vary, depending on the reason for anticoagulation. For example, a patient having hip surgery, who is being anticoagulated to prevent deep vein thrombosis, may have a target INR of between two and three. To prevent arterial thrombosis in a patient with an artificial heart valve, the INR therapeutic goal may be in the 2.5- to 3.5-range.

Several medical manufacturers have gained CLIA-waived status for their PT test devices, allowing rapid assessment in the point of care setting, and, in the cases of several waived-devices, in the patients home as well. Roche Diagnostics Corporation, Indianapolis, Ind., a division of Swiss F. Hoffmann-La Roche Ltd, produces the CoaguChek S System, designed for health care professionals to enable on-the-spot analysis of coagulation levels during mobile emergency treatment, in hospital and in general practice. The device employs electromagnetic field kinetics to determine PT. A single d
'"/>




Page: 1 2 3

Related medicine technology :

1. New Advances in Gastric Diagnostics: Smaller is Better
2. Bench-Top Centrifuges--Basic Tools for the Small Lab
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prothrombin Time Comes Small CLIA Waived Packages
(Date:3/10/2010)... , March 10 CVS Caremark Corporation (NYSE: CVS ) today announced that its Board of Directors has approved a quarterly ... April 23, 2010 . , ... , , ... ... ...
(Date:3/10/2010)... ... ... ... ... ...
(Date:3/10/2010)... , ... ... ... , ... ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Quarterly Dividend 2CareFusion Launches New Pyxis ProcedureStation(TM) Radio Frequency Identification System at Association of Perioperative Registered Nurses 57th Annual Congress 2CareFusion Launches New Pyxis ProcedureStation(TM) Radio Frequency Identification System at Association of Perioperative Registered Nurses 57th Annual Congress 3CareFusion Launches New Pyxis ProcedureStation(TM) Radio Frequency Identification System at Association of Perioperative Registered Nurses 57th Annual Congress 4U.S. Surgeon General Dr. Regina M. Benjamin to Deliver Commencement Address at Albany College of Pharmacy and Health Sciences 2U.S. Surgeon General Dr. Regina M. Benjamin to Deliver Commencement Address at Albany College of Pharmacy and Health Sciences 3U.S. Surgeon General Dr. Regina M. Benjamin to Deliver Commencement Address at Albany College of Pharmacy and Health Sciences 4Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an Effective Malaria Vaccine 66088 1Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an Effective Malaria Vaccine 66088 2Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an Effective Malaria Vaccine 66088 3Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an Effective Malaria Vaccine 66088 4New Book Reveals Secrets about the Health Insurance Industry 66086 1New Book Reveals Secrets about the Health Insurance Industry 66086 2New Book Reveals Secrets about the Health Insurance Industry 66086 3New Book 26quot 3BHealing 26quot 3B Claims 26quot 3BWhat 26apos 3Bs Ailing The U S is What 26apos 3Bs Ailing Us All 26quot 3B Offers Healing Se 66084 1New Book 26quot 3BHealing 26quot 3B Claims 26quot 3BWhat 26apos 3Bs Ailing The U S is What 26apos 3Bs Ailing Us All 26quot 3B Offers Healing Se 66084 2New Book 26quot 3BHealing 26quot 3B Claims 26quot 3BWhat 26apos 3Bs Ailing The U S is What 26apos 3Bs Ailing Us All 26quot 3B Offers Healing Se 66084 3New Book 26quot 3BHealing 26quot 3B Claims 26quot 3BWhat 26apos 3Bs Ailing The U S is What 26apos 3Bs Ailing Us All 26quot 3B Offers Healing Se 66084 4New Book 26quot 3BHealing 26quot 3B Claims 26quot 3BWhat 26apos 3Bs Ailing The U S is What 26apos 3Bs Ailing Us All 26quot 3B Offers Healing Se 66084 5
... Major Secondary Endpoints in the Largest ... in Psoriatic Arthritis, BOSTON, Nov. 7 ... injections of golimumab (CNTO 148),experienced significant and sustained ... disease, according to findings from the largest Phase,3 ...
... Paramount Concern, SEATTLE, Nov. 7 The AIDS ... Executive,Director Mitchell Warren in response to the release of ... & Co., the US National Institute for,Allergy and Infectious ... a public forum at the HVTN meeting today., ...
Other Medicine Technology:Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 2Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 3Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 4Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 5Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 6Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 7Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis 8AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 2AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 3
(Date:3/10/2010)... the University of Wisconsin-Madison for the 16th annual symposium on emotion ... to disease and treatment. , ... Madison, WI (Vocus) ... of Wisconsin-Madison for the 16th annual symposium on emotion in April ... and treatment., , , , ,The brain is a very plastic ...
(Date:3/10/2010)... screening in groundbreaking publication, , ... ... released its first ever Annual Report on Prostate Diseases, which ... cancer, benign prostatic hyperplasia (BPH), erectile dysfunction, prostatitis, and related ... of talented prostate disease specialists contributed to the publication., , ...
(Date:3/10/2010)... at Johns Hopkins Medical Institutions, the Karolinska University Hospital and ... substance called Eprotirome in patients with high cholesterol. , ... ... -- An experimental thyroid drug reduces cholesterol without the troublesome ... a study published today in The New England Journal of ...
(Date:3/10/2010)... tests have conclusively demonstrated that BIOSECUR Lab, ... effective against the most prevalent and deadly ... the U.S. Food and Drug Administration’s (FDA’s) ... demonstrated that BIOSECUR antimicrobial product kills more ... and E. coli, just 15- to 30-seconds ...
(Date:3/10/2010)... mysteries of neurological and motor disease, , , WEDNESDAY, March ... the relationship between tobacco smoke and Parkinson,s disease, researchers ... risk for the disease but smoking a large number ... risk. , Previous research had suggested that smokers have ... finding, however, comes with a caveat. , "Given ...
Breaking Medicine News(10 mins):Health News:UW Symposium: How Disease, Therapy, Drugs and Meditation Reshape the Brain, 2Health News:UW Symposium: How Disease, Therapy, Drugs and Meditation Reshape the Brain, 3Health News:Harvard Medical School releases 2010 Annual Report on Prostate Diseases, 2Health News:Harvard Medical School releases 2010 Annual Report on Prostate Diseases, 3Health News:Thyroid Hormone Analogue for Treating High Cholesterol 2Health News:Thyroid Hormone Analogue for Treating High Cholesterol 3Health News:Certified Organic Biosecur™ Product Line Proven Effective Against Foodborne Pathogens Responsible For $152 Billion in Annual Health-Related Expenses 2Health News:Certified Organic Biosecur™ Product Line Proven Effective Against Foodborne Pathogens Responsible For $152 Billion in Annual Health-Related Expenses 3Health News:Certified Organic Biosecur™ Product Line Proven Effective Against Foodborne Pathogens Responsible For $152 Billion in Annual Health-Related Expenses 4Health News:Longtime Smokers May Find Protection From Parkinson's 2
... of Medicine and Public Health had found that children ... treatments might be treated with implantation of a vagus ... ,As an alternative to medication, the FDA had approved ... patients older than 12 to help control or reduce ...
... encourager the children to eat healthy. This is ... ,Researchers from Finland’s University of Turku had found ... habits among children with a family history of ... unhealthy behaviors are significant risk factors for heart ...
... inherited disease in which the oxygen-carrying protein in the ... a twisted (sickled) shape that can disrupt circulation, leading ... complications. // ,"Sickle cell anemia is a ... according to Dr.Ware, an expert in the field of ...
... Amphetamine, which are used as a Party drug ecstasy, ... University of Brimingham, in a new study have found ... Lymphoma. // ,John Gordon and his team from ... involved in mediating apoptosis in lymphoma cells. These anti-depressant ...
... developed a way to print DNA (Deoxyribonucleic Acid), which ... cheap as blood tests. ,The technique called Supramolecular ... are not generally used in medical diagnostics.// ... and his colleagues at the Massachusetts Institute of Technology ...
... Not, if latest research is to be believed. Venting ... very beneficial to health. ,Researchers at the ... there are interesting links between language content and health ... has health benefits. If people write out their feelings, ...
Other Medicine News:Health News:Children With Epilepsy Can Be Treated With Nerve Stimulation 2Health News:Initiation Of New Study To Help Children With Sickle Cell Anaemia 2
... kits provide convenience and cost control. , ... trays offer a variety of wound dressing ... of the tracheostomized patient. , ,Tray ... trays with disposable inner cannula for both ...
... filled cuff conforms to the ... trachea. During mechanical ventilation the ... lowest possible cuff to tracheal ... the ventilatory cycle. This provides ...
Disposable tracheostomy care tray....
Disposable tracheostomy care tray....
Medicine Products: